Immunobiome

Developer of microbiome therapeutics for autoimmunity, cancer, and autism spectrum disorders

placePohang, Gyeongsangbuk-do, South Korea calendar_todayFounded 2019 groups23 employees language immunobiome.co.kr

Innovation

13 patent families (3 granted) — focus: Human necessities, Physics & computing; filing pace accelerating. Cited 255 times.

YearFilings
20211
20223
20234
20249
20255

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Accelerator & incubator125%
Bank & private debt125%
Coming soon